Literature DB >> 25599908

Editorial: utility and pitfalls of Fatty Liver Index in epidemiologic studies for the diagnosis of NAFLD.

E Vanni1, E Bugianesi.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25599908     DOI： 10.1111/apt.13063

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  8 in total

1.  Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease.

Authors:  Yuan-Lung Cheng; Yuan-Jen Wang; Keng-Hsin Lan; Teh-Ia Huo; Yi-Hsiang Huang; Chien-Wei Su; Wei-Yao Hsieh; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu; Shou-Dong Lee
Journal:  Gastroenterol Res Pract       Date:  2017-01-17       Impact factor: 2.260

2.  Links between gut microbiome composition and fatty liver disease in a large population sample.

Authors:  Matti O Ruuskanen; Fredrik Åberg; Ville Männistö; Aki S Havulinna; Guillaume Méric; Yang Liu; Rohit Loomba; Yoshiki Vázquez-Baeza; Anupriya Tripathi; Liisa M Valsta; Michael Inouye; Pekka Jousilahti; Veikko Salomaa; Mohit Jain; Rob Knight; Leo Lahti; Teemu J Niiranen
Journal:  Gut Microbes       Date:  2021 Jan-Dec

3.  Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis.

Authors:  Marco Castellana; Rossella Donghia; Vito Guerra; Filippo Procino; Luisa Lampignano; Fabio Castellana; Roberta Zupo; Rodolfo Sardone; Giovanni De Pergola; Francesco Romanelli; Pierpaolo Trimboli; Gianluigi Giannelli
Journal:  J Clin Med       Date:  2021-04-26       Impact factor: 4.241

4.  Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification.

Authors:  Guoyan Jiang; Chunhong Sun; Xiaodong Wang; Jie Mei; Chen Li; Honghong Zhan; Yixuan Liao; Yongjun Zhu; Jingxin Mao
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

5.  External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.

Authors:  Liuxin Zhang; Mengting Zhang; Min Wang; Minxian Wang; Ru Zhang; Hongliang Wang; Wei Zhang; Yajie Ding; Jie Wang
Journal:  Eur J Gastroenterol Hepatol       Date:  2022-06-29       Impact factor: 2.586

6.  The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings.

Authors:  Mawanane Hewa Aruna Devapriya de Silva; Ruwani Punyakanthi Hewawasam; Chanika Roshini Kulatunge; Rathnayake Mudiyanselage Anjali Chamika
Journal:  BMC Pediatr       Date:  2022-08-30       Impact factor: 2.567

7.  Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease.

Authors:  Tiia N K Mäkelä; Tomi-Pekka Tuomainen; Sari Hantunen; Jyrki K Virtanen
Journal:  Am J Clin Nutr       Date:  2022-09-02       Impact factor: 8.472

8.  Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.

Authors:  Masato Yoneda; Takuma Yamamoto; Yasushi Honda; Kento Imajo; Yuji Ogawa; Takaomi Kessoku; Takashi Kobayashi; Asako Nogami; Takuma Higurashi; Shingo Kato; Kunihiro Hosono; Satoru Saito; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2021-10-03       Impact factor: 7.527
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.